Trial Profile
A randomised, cross-over phase I/II trial of PD-protec in patients with kidney failure.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 May 2015
Price :
$35
*
At a glance
- Drugs Alanylglutamine (Primary)
- Indications Renal failure
- Focus Adverse reactions; Therapeutic Use
- 06 May 2015 New trial record